More aggressive high-grade lymphomas are treated for cure. Although chemotherapy and radiotherapy remain the mainstays of treatment, immunotherapy demonstrates increasing promise.Reed-Sternberg Cells
The treatment of Hodgkin lymphoma has improved dramatically over the last 20 years, with advances in imaging techniques. In the early stages, this cancer of the immune system can be cured with a 95 percent success rate by a combination of radiation and chemotherapy. The major challenge is choos...
Non-Hodgkin's-lymphoma, treatmentProduct-approvalsRituximab, therapeutic useBACKGROUND: Rituximab, a monoclonal anti-CD20 antibody, in combination with chemotherapy improves overall survival compared to chemotherapy alone when used for induction therapy for patients with newly diagnosed or relapsed indolent ...